N-[(2-hydroxy-4-methyl-6-propylphenyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;methane;N-[(6-methyl-4-oxo-1-prop-2-enoyl-2-propyl-3-pyridinyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-N-[[4-methyl-2-(prop-2-enoylamino)-6-propylphenyl]methyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide

C101H133N23O7 — CID 157317281

IUPACN-[(2-hydroxy-4-methyl-6-propylphenyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;methane;N-[(6-methyl-4-oxo-1-prop-2-enoyl-2-propyl-3-pyridinyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-N-[[4-methyl-2-(prop-2-enoylamino)-6-propylphenyl]methyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide
SMILESC.C.C.C=CC(=O)Nc1cc(C)cc(CCC)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C.C=CC(=O)n1c(C)cc(=O)c(CNC(=O)c2cc(-c3ccc(N4CCN(C)CC4)nc3)nc3c2cnn3C(C)C)c1CCC.CCCc1cc(C)cc(O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C
InChIInChI=1S/C34H42N8O2.C33H40N8O3.C31H39N7O2.3CH4/c1-7-9-24-16-23(5)17-30(38-32(43)8-2)27(24)20-36-34(44)26-18-29(39-33-28(26)21-37-42(33)22(3)4)25-10-11-31(35-19-25)41-14-12-40(6)13-15-41;1-7-9-28-26(29(42)16-22(5)40(28)31(43)8-2)19-35-33(44)24-17-27(37-32-25(24)20-36-41(32)21(3)4)23-10-11-30(34-18-23)39-14-12-38(6)13-15-39;1-6-7-22-14-21(4)15-28(39)25(22)18-33-31(40)24-16-27(35-30-26(24)19-34-38(30)20(2)3)23-8-9-29(32-17-23)37-12-10-36(5)11-13-37;;;/h8,10-11,16-19,21-22H,2,7,9,12-15,20H2,1,3-6H3,(H,36,44)(H,38,43);8,10-11,16-18,20-21H,2,7,9,12-15,19H2,1,3-6H3,(H,35,44);8-9,14-17,19-20,39H,6-7,10-13,18H2,1-5H3,(H,33,40);3*1H4
InChIKeyBDTGFQKKHPXXOF-UHFFFAOYSA-N
MW1781.33 g/mol
LogP15.78
Rot. Bonds27

About N-[(2-hydroxy-4-methyl-6-propylphenyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;methane;N-[(6-methyl-4-oxo-1-prop-2-enoyl-2-propyl-3-pyridinyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-N-[[4-methyl-2-(prop-2-enoylamino)-6-propylphenyl]methyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide

N-[(2-hydroxy-4-methyl-6-propylphenyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;methane;N-[(6-methyl-4-oxo-1-prop-2-enoyl-2-propyl-3-pyridinyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-N-[[4-methyl-2-(prop-2-enoylamino)-6-propylphenyl]methyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide (PubChem CID 157317281) has the molecular formula C101H133N23O7 and a molecular weight of 1781.33 g/mol. Its IUPAC name is N-[(2-hydroxy-4-methyl-6-propylphenyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;methane;N-[(6-methyl-4-oxo-1-prop-2-enoyl-2-propyl-3-pyridinyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-N-[[4-methyl-2-(prop-2-enoylamino)-6-propylphenyl]methyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide.

Molecular Properties

Compound NameN-[(2-hydroxy-4-methyl-6-propylphenyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;methane;N-[(6-methyl-4-oxo-1-prop-2-enoyl-2-propyl-3-pyridinyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-N-[[4-methyl-2-(prop-2-enoylamino)-6-propylphenyl]methyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide
PubChem CID157317281
Molecular FormulaC101H133N23O7
Molecular Weight1781.33 g/mol
Exact Mass1780.08
IUPAC NameN-[(2-hydroxy-4-methyl-6-propylphenyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;methane;N-[(6-methyl-4-oxo-1-prop-2-enoyl-2-propyl-3-pyridinyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-N-[[4-methyl-2-(prop-2-enoylamino)-6-propylphenyl]methyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide
SMILESC.C.C.C=CC(=O)Nc1cc(C)cc(CCC)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C.C=CC(=O)n1c(C)cc(=O)c(CNC(=O)c2cc(-c3ccc(N4CCN(C)CC4)nc3)nc3c2cnn3C(C)C)c1CCC.CCCc1cc(C)cc(O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C
InChIInChI=1S/C34H42N8O2.C33H40N8O3.C31H39N7O2.3CH4/c1-7-9-24-16-23(5)17-30(38-32(43)8-2)27(24)20-36-34(44)26-18-29(39-33-28(26)21-37-42(33)22(3)4)25-10-11-31(35-19-25)41-14-12-40(6)13-15-41;1-7-9-28-26(29(42)16-22(5)40(28)31(43)8-2)19-35-33(44)24-17-27(37-32-25(24)20-36-41(32)21(3)4)23-10-11-30(34-18-23)39-14-12-38(6)13-15-39;1-6-7-22-14-21(4)15-28(39)25(22)18-33-31(40)24-16-27(35-30-26(24)19-34-38(30)20(2)3)23-8-9-29(32-17-23)37-12-10-36(5)11-13-37;;;/h8,10-11,16-19,21-22H,2,7,9,12-15,20H2,1,3-6H3,(H,36,44)(H,38,43);8,10-11,16-18,20-21H,2,7,9,12-15,19H2,1,3-6H3,(H,35,44);8-9,14-17,19-20,39H,6-7,10-13,18H2,1-5H3,(H,33,40);3*1H4
InChIKeyBDTGFQKKHPXXOF-UHFFFAOYSA-N
XLogP15.78
TPSA325.94 Ų
H-Bond Donors5
H-Bond Acceptors26
Rotatable Bonds27
Heavy Atoms131
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001781.33
LogP ≤ 515.78
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'mannich_A(296)', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze N-[(2-hydroxy-4-methyl-6-propylphenyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;methane;N-[(6-methyl-4-oxo-1-prop-2-enoyl-2-propyl-3-pyridinyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-N-[[4-methyl-2-(prop-2-enoylamino)-6-propylphenyl]methyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(2-hydroxy-4-methyl-6-propylphenyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;methane;N-[(6-methyl-4-oxo-1-prop-2-enoyl-2-propyl-3-pyridinyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-N-[[4-methyl-2-(prop-2-enoylamino)-6-propylphenyl]methyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide?
The IUPAC name of N-[(2-hydroxy-4-methyl-6-propylphenyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;methane;N-[(6-methyl-4-oxo-1-prop-2-enoyl-2-propyl-3-pyridinyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-N-[[4-methyl-2-(prop-2-enoylamino)-6-propylphenyl]methyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide (CID 157317281) is N-[(2-hydroxy-4-methyl-6-propylphenyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;methane;N-[(6-methyl-4-oxo-1-prop-2-enoyl-2-propyl-3-pyridinyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-N-[[4-methyl-2-(prop-2-enoylamino)-6-propylphenyl]methyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide.
What is the SMILES notation for N-[(2-hydroxy-4-methyl-6-propylphenyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;methane;N-[(6-methyl-4-oxo-1-prop-2-enoyl-2-propyl-3-pyridinyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-N-[[4-methyl-2-(prop-2-enoylamino)-6-propylphenyl]methyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide?
The canonical SMILES for N-[(2-hydroxy-4-methyl-6-propylphenyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;methane;N-[(6-methyl-4-oxo-1-prop-2-enoyl-2-propyl-3-pyridinyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-N-[[4-methyl-2-(prop-2-enoylamino)-6-propylphenyl]methyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide is C.C.C.C=CC(=O)Nc1cc(C)cc(CCC)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C.C=CC(=O)n1c(C)cc(=O)c(CNC(=O)c2cc(-c3ccc(N4CCN(C)CC4)nc3)nc3c2cnn3C(C)C)c1CCC.CCCc1cc(C)cc(O)c1CNC(=O)c1cc(-c2ccc(N3CCN(C)CC3)nc2)nc2c1cnn2C(C)C.
What is the InChIKey of N-[(2-hydroxy-4-methyl-6-propylphenyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;methane;N-[(6-methyl-4-oxo-1-prop-2-enoyl-2-propyl-3-pyridinyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-N-[[4-methyl-2-(prop-2-enoylamino)-6-propylphenyl]methyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide?
The InChIKey is BDTGFQKKHPXXOF-UHFFFAOYSA-N. The full InChI is InChI=1S/C34H42N8O2.C33H40N8O3.C31H39N7O2.3CH4/c1-7-9-24-16-23(5)17-30(38-32(43)8-2)27(24)20-36-34(44)26-18-29(39-33-28(26)21-37-42(33)22(3)4)25-10-11-31(35-19-25)41-14-12-40(6)13-15-41;1-7-9-28-26(29(42)16-22(5)40(28)31(43)8-2)19-35-33(44)24-17-27(37-32-25(24)20-36-41(32)21(3)4)23-10-11-30(34-18-23)39-14-12-38(6)13-15-39;1-6-7-22-14-21(4)15-28(39)25(22)18-33-31(40)24-16-27(35-30-26(24)19-34-38(30)20(2)3)23-8-9-29(32-17-23)37-12-10-36(5)11-13-37;;;/h8,10-11,16-19,21-22H,2,7,9,12-15,20H2,1,3-6H3,(H,36,44)(H,38,43);8,10-11,16-18,20-21H,2,7,9,12-15,19H2,1,3-6H3,(H,35,44);8-9,14-17,19-20,39H,6-7,10-13,18H2,1-5H3,(H,33,40);3*1H4.
What are the key properties of N-[(2-hydroxy-4-methyl-6-propylphenyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;methane;N-[(6-methyl-4-oxo-1-prop-2-enoyl-2-propyl-3-pyridinyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-N-[[4-methyl-2-(prop-2-enoylamino)-6-propylphenyl]methyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide?
N-[(2-hydroxy-4-methyl-6-propylphenyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;methane;N-[(6-methyl-4-oxo-1-prop-2-enoyl-2-propyl-3-pyridinyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-N-[[4-methyl-2-(prop-2-enoylamino)-6-propylphenyl]methyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide has a molecular weight of 1781.33 g/mol, XLogP of 15.78, 27 rotatable bonds, 5 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2-hydroxy-4-methyl-6-propylphenyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;methane;N-[(6-methyl-4-oxo-1-prop-2-enoyl-2-propyl-3-pyridinyl)methyl]-6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;6-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]-N-[[4-methyl-2-(prop-2-enoylamino)-6-propylphenyl]methyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide is sourced from PubChem (CID 157317281), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).